ROIV – roivant sciences ltd. (US:NASDAQ)

News

Roivant Sciences (ROIV) is now covered by Sanford C. Bernstein. They set an "outperform" rating and a $35.00 price target on the stock.
REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD [Yahoo! Finance]
A Look At Roivant Sciences (ROIV) Valuation After Recent Share Price Strength [Yahoo! Finance]
Roivant Sciences (ROIV) had its "buy" rating reaffirmed by TD Cowen.
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com